Clinical trial
Withdrawal of Inhaled Corticosteroids in Patients With COPD in Primary Care
NCT00440687 · Queen Mary University of London, Other · Completed
Key facts
| NCT number | NCT00440687 |
|---|---|
| Title | Withdrawal of Inhaled Corticosteroids in Patients With COPD in Primary Care |
| Official title | Phase 4 Withdrawal of Inhaled Corticosteroids in Patients With Chronic Obstructive Pulmonary Disease in Primary Care: a Randomised Controlled Trial |
| Lead sponsor | Queen Mary University of London, Other |
| Collaborators | British Lung Foundation GlaxoSmithKline Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Chronic Obstructive Pulmonary Disease |
| Intervention type | Drug |
| Interventions | Fluticasone 500mcg BD via accuhaler or identical placebo |
| Enrollment | 256 |
| Start date | Jan 1, 2001 |
| Completion | Mar 1, 2004 |
| First posted | Feb 27, 2007 |
| Last update posted | Feb 27, 2007 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: